in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Cambrex reports huge fall in profits
11:36 AM MDT | August 1, 2013 | Deepti Ramesh
Cambrex (East Rutherford, NJ) reports a 77% fall in net profits for the second quarter, ended 30 June, compared with the year-ago quarter, to $2.27 million. Net sales for the second quarter decreased 19.3%, to $61.5 million, primarily because of lower sales of controled substances and generic active pharmaceutical ingredients, Cambrex says. For the first six months of 2013, Cambrex reports a 20.7% fall in profits, compared with the first six months of 2012, to $13.4 million. Net sales in the first-half decreased by 7.1%, to $135.9 million. “The...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee